Abstract
The pathologic mechanisms underlying sulfur mustard (HD)-induced skin vesication are as yet undefined. Papirmeister et al. (1985) postulate enhanced proteolytic activity as a proximate cause of HD-induced cutaneous injury. Using a chromogenic peptide substrate assay, we previously reported that in vitro exposure of cell cultures to HD enhances proteolytic activity. We have continued our investigation of HD-increased proteolytic activity in vitro and have expanded our studies to include an in vivo animal model for HD exposure. In vitro exposure of human peripheral blood lymphocytes (PBL) to HD demonstrated that the increase in proteolytic activity is both time- and temperature-dependent. Using a panel of 10 protease substrates, we established that, the HD-increased proteolysis was markedly different from that generated by plasminogen activator. The hairless guinea pig is an animal model used for the study of HD-induced dermal pathology. When control and HD-exposed PBL and hairless guinea pig skin where examined, similarities in their protease substrate reactivities were observed. HD-exposed hairless guinea pig skin biopsies demonstrated increased proteolytic activity that was time-dependent. The HD-increased proteolytic response was similar in both in vitro and in vivo studies and may be useful for elucidating both the mechanism of HD-induced vesication and potential treatment compounds.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- CPSPA:
-
chromogenic peptide substrate protease assay
- HD:
-
sulfur mustard
- PBL:
-
human peripheral blood lymphocytes
- pNA:
-
p-nitroaniline
References
BOYUM, A. (1968). “Separation of leukocytes from blood and bone marrow.” Scand. J. Clin. Lab. Invest. 21 (suppl. 97): 1–106.
COOPER, T.W., BAUER, E.A., and BRIGGAMAN, R.A. (1987). “The mechanobullous disease (Epidermolysis bullosa).” In: Dermatology in General Medicine (T.B. Fitzpatrick, A.Z. Eisen, and K. Wolff, eds.). Vol. 3. McGraw-Hill, New York. pp. 610–626.
COWAN, F.M., and BROOMFIELD, C.A. (1993). “Putative roles of inflammation in the dermatopathology of sulfur mustard.” Cell Biol. Toxicol. 9: 201–213.
COWAN, F.M., BROOMFIELD, C.A., and SMITH, W.J. (1991). “Effect of sulfur mustard on protease activity in human peripheral blood lymphocytes.” Cell Biol. Toxicol. 7: 239–248.
COWAN, F.M., BROOMFIELD, C.A., and SMITH, W.J. (1992). “Inhibition of sulfur mustard-increased protease activity by niacinamide,N-acetyl-l-cysteine or dexamethasone.” Cell Biol. Toxicol. 8: 129–133.
FRIBERGER, P. (1982). “Chromogenic peptide substrates.” Scand. J. Clin. Lab Invest. 42 (suppl. 162): 1–98.
KAHL, F.R., and PEARSON, R.W. (1967). “Ultrastructural studies of experimental vesiculation. I: Papain.” J. Invest. Dermatol. 49: 43–59.
LISON, D., DEJARDIN, L., and SIMON, O. (1991). “Effects of sulfur mustard on plasminogen activator activity of human keratinocytes in cultures.” Ann. Med. Milit. Belg. 5: 11–15.
MEIER, H.L., GROSS, C.L., and PAPIRMEISTER, B. (1987). “2,2′-Dichloroediethyl sulfide sulfur mustard) decreases NAD+ in human leukocytes.” Toxicol. Lett. 39: 109–122.
MERSHON, M.M., WADE, J.V., MITCHELTREE, L.W., PETRALI, J.P., and BRAUE, E.H. (1990). “The hairless guinea pig bioassay model for vesicant vapor exposures.” Fund. Appl. Toxicol. 15: 622–630.
PAPIRMEISTER, B., GROSS, C.L., MEIER, H.L., PETRALI, J.P., and JOHNSON, J.B. (1985). “Molecular basis for mustard-induced vesication.” Fund. Appl. Toxicol. 5: S134-S149.
PAPIRMEISTER, B., FEISTER, A.J., ROBINSON, S.I., and FORD, R.D. (1991). “Medical Defense Against Mustard Gas: Mechanisms and Pharmacological Implications.” CRC Press, Boston. pp. 1–359.
RIKIMARU, T., NAKAMURA, M., YANO, T.S. BECK, G., HABICHT, G.S., RENNIE, L.L., WIDRA, M., HIRSHMAN, C.A., BOULAY, M.G., SPANNHAKE, E.W., LAZARUS, G.S., PULA, P.J., and DANNENBERG, A.M. (1991). “Mediators, initiating the inflammatory response, released in organ culture by full-thickness human skin explants exposed to the irritant, sulfur mustard.” J. Invest. Dermatol. 96: 888–897.
SMITH, W.J., and GROSS, C.L. (1991). “Early events in the pathology of sulfur mustardin vitro: Approaches to intervention.” Proceedings of the NATO, Panel VIII Meeting, Grenoble, France.
SMITH, W.J., SANDERS, K.M., GALES, Y.A., and GROSS, C.L. (1991). “Flow cytometric analysis of toxicity by vesicating agents in human cellsin vitro.” J. Toxicol. Cutan. Ocular Toxicol. 10: 33–42.
YOURICK, J.J., CLARK, C.R., and MITCHELTREE, L.W. (1991). “Niacinamide pretreatment reduces microvesicle formation in hairless guinea pigs cutaneously exposed to sulfur mustard.” Fund. Appl. Toxicol. 17: 533–542.
Author information
Authors and Affiliations
Additional information
In conducting the research described in this report, the investigators adhered to the “Guide for the Care and Use of Laboratory Animals”, NIH Publication No. 85-23, revised 1985.
The opinions or assertions contained herein are the private views of the authors and are not to be construed as official or as reflecting the views of the Department of the Army or the Department of Defense.
Rights and permissions
About this article
Cite this article
Cowan, F.M., Yourick, J.J., Hurst, C.G. et al. Sulfur mustard-increased proteolysis followingin vitro andin vivo exposures. Cell Biol Toxicol 9, 269–277 (1993). https://doi.org/10.1007/BF00755605
Issue Date:
DOI: https://doi.org/10.1007/BF00755605